See also this year's filing and all EDGAR filings for this company.
PDF Report 0000847464_2019_SPRING_PHARMACEUTICAL_GROUP_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000847464')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000847464, SPRING PHARMACEUTICAL GROUP INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 30,065,747 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 11,862,017 |
| 2 | PropertyPlantAndEquipmentNet | 16,793,413 |
| 3 | remainder_Assets | 51,416,922 |
| 4 | LiabilitiesCurrent | 1,982,809 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 39,603,995 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,719,402 |
| 9 | ResearchAndDevelopmentExpense | 492,078 |
| 10 | remainder_Expenses | 9,155,716 |
| 11 | remainder_Revenues | 64,942,737 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 9,115,321 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 110,138,099 |
| 1 | Liabilities | 1,982,809 |
| 2 | Expenses | 53,971,191 |
| 3 | Revenues | 64,942,737 |
| 4 | StockholdersEquity | 108,155,290 |
| 5 | NetIncome | 10,971,546 |
| 6 | ComprehensiveNetIncome | 15,529,206 |
| 7 | BaseVar | 120,075,078 |
| 8 | EconomicCapitalRatio | 3.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
